Oral peptide delivery by tetraether lipid liposomes
The aim of this study is to improve of oral peptide delivery by a novel type of liposomes containing tetraether lipids (TELs) derived from archaea bacteria. Liposomes were used for the oral delivery of the somatostatin analogue octreotide. TELs were extracted from Sulfolobus acidocaldarius and subse...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2 June 2011
|
| In: |
International journal of pharmaceutics
Year: 2011, Jahrgang: 415, Heft: 1-2, Pages: 150-157 |
| ISSN: | 1873-3476 |
| DOI: | 10.1016/j.ijpharm.2011.05.066 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.ijpharm.2011.05.066
|
| Verfasserangaben: | Johannes Parmentier, Bernhard Thewes, Felix Gropp, Gert Fricker |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1817214209 | ||
| 003 | DE-627 | ||
| 005 | 20230710114213.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220921s2011 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ijpharm.2011.05.066 |2 doi | |
| 035 | |a (DE-627)1817214209 | ||
| 035 | |a (DE-599)KXP1817214209 | ||
| 035 | |a (OCoLC)1389785237 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 32 |2 sdnb | ||
| 100 | 1 | |a Parmentier, Johannes |e VerfasserIn |0 (DE-588)1019157801 |0 (DE-627)684202662 |0 (DE-576)357136225 |4 aut | |
| 245 | 1 | 0 | |a Oral peptide delivery by tetraether lipid liposomes |c Johannes Parmentier, Bernhard Thewes, Felix Gropp, Gert Fricker |
| 264 | 1 | |c 2 June 2011 | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 21.09.2022 | ||
| 520 | |a The aim of this study is to improve of oral peptide delivery by a novel type of liposomes containing tetraether lipids (TELs) derived from archaea bacteria. Liposomes were used for the oral delivery of the somatostatin analogue octreotide. TELs were extracted from Sulfolobus acidocaldarius and subsequently purified to single compounds. Liposomes were prepared by the film method followed by extrusion. Vesicles in size between 130 and 207 nm were obtained as confirmed by photon correlation spectroscopy. The pharmacokinetics of radiolabeled TELs in liposomes was investigated after oral administration to rats. 1.6% of the applied radioactivity in fed and 1.5% in fasted rats was recovered in the blood and inner organs after 2h, while most of the radioactivity remained in the gastro-intestinal tract. After 24h the percentage of radioactivity in inner organs was reduced to 0.6% in fed rats, respectively 1.0% in fasted animals. Several liposomal formulations containing dipalmitoyl phosphatidylcholine (DPPC) and TELs in different ratios were loaded with octreotide and orally administered. Liposomes with 25% TEL could improve the oral bioavailability of octreotide 4.1-fold and one formulation with a cationic TEL derivative 4.6-fold. TEL-liposomes probably act by protecting the peptide in the gastro-intestinal tract. | ||
| 650 | 4 | |a Animals | |
| 650 | 4 | |a Biological Availability | |
| 650 | 4 | |a Chromatography, High Pressure Liquid | |
| 650 | 4 | |a Diglycerides | |
| 650 | 4 | |a Drug Carriers | |
| 650 | 4 | |a Drug Compounding | |
| 650 | 4 | |a Drug Stability | |
| 650 | 4 | |a Glycolipids | |
| 650 | 4 | |a Liposomes | |
| 650 | 4 | |a Male | |
| 650 | 4 | |a Molecular Structure | |
| 650 | 4 | |a Octreotide | |
| 650 | 4 | |a Particle Size | |
| 650 | 4 | |a Peptides | |
| 650 | 4 | |a Rats | |
| 650 | 4 | |a Rats, Wistar | |
| 650 | 4 | |a Spectroscopy, Fourier Transform Infrared | |
| 650 | 4 | |a Sulfolobus acidocaldarius | |
| 650 | 4 | |a Tissue Distribution | |
| 700 | 1 | |a Thewes, Bernhard |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gropp, Felix |e VerfasserIn |4 aut | |
| 700 | 1 | |a Fricker, Gert |d 1956- |e VerfasserIn |0 (DE-588)1042227675 |0 (DE-627)768469465 |0 (DE-576)393783464 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International journal of pharmaceutics |d New York, NY [u.a.] : Elsevier, 1978 |g 415(2011), 1-2, Seite 150-157 |h Online-Ressource |w (DE-627)301512817 |w (DE-600)1484643-3 |w (DE-576)081952708 |x 1873-3476 |7 nnas |a Oral peptide delivery by tetraether lipid liposomes |
| 773 | 1 | 8 | |g volume:415 |g year:2011 |g number:1-2 |g pages:150-157 |g extent:8 |a Oral peptide delivery by tetraether lipid liposomes |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.ijpharm.2011.05.066 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20220921 | ||
| 993 | |a Article | ||
| 994 | |a 2011 | ||
| 998 | |g 1042227675 |a Fricker, Gert |m 1042227675:Fricker, Gert |d 160000 |d 160100 |e 160000PF1042227675 |e 160100PF1042227675 |k 0/160000/ |k 1/160000/160100/ |p 4 |y j | ||
| 998 | |g 1019157801 |a Parmentier, Johannes |m 1019157801:Parmentier, Johannes |d 160000 |d 160100 |e 160000PP1019157801 |e 160100PP1019157801 |k 0/160000/ |k 1/160000/160100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1817214209 |e 4190514373 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"id":{"eki":["1817214209"],"doi":["10.1016/j.ijpharm.2011.05.066"]},"physDesc":[{"extent":"8 S."}],"note":["Gesehen am 21.09.2022"],"relHost":[{"pubHistory":["1.1978 -"],"title":[{"title_sort":"International journal of pharmaceutics","title":"International journal of pharmaceutics"}],"language":["eng"],"part":{"issue":"1-2","pages":"150-157","extent":"8","year":"2011","text":"415(2011), 1-2, Seite 150-157","volume":"415"},"origin":[{"publisherPlace":"New York, NY [u.a.]","dateIssuedKey":"1978","dateIssuedDisp":"1978-","publisher":"Elsevier"}],"recId":"301512817","type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Oral peptide delivery by tetraether lipid liposomesInternational journal of pharmaceutics","physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["1484643-3"],"issn":["1873-3476"],"eki":["301512817"]},"note":["Gesehen am 23.09.2021"]}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedKey":"2011","dateIssuedDisp":"2 June 2011"}],"recId":"1817214209","person":[{"family":"Parmentier","display":"Parmentier, Johannes","given":"Johannes","role":"aut"},{"given":"Bernhard","role":"aut","display":"Thewes, Bernhard","family":"Thewes"},{"given":"Felix","role":"aut","display":"Gropp, Felix","family":"Gropp"},{"family":"Fricker","display":"Fricker, Gert","given":"Gert","role":"aut"}],"name":{"displayForm":["Johannes Parmentier, Bernhard Thewes, Felix Gropp, Gert Fricker"]},"title":[{"title_sort":"Oral peptide delivery by tetraether lipid liposomes","title":"Oral peptide delivery by tetraether lipid liposomes"}],"language":["eng"]} | ||
| SRT | |a PARMENTIERORALPEPTID2201 | ||